Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
King B, Soung J, Tziotzios C, Rudnicka L, Joly P, Gooderham M, Sinclair R, Mesinkovska NA, Paul C, Gong Y, Anway SD, Tran H, Wolk R, Zwillich SH, Lejeune A. King B, et al. Among authors: gong y. Am J Clin Dermatol. 2024 May 24. doi: 10.1007/s40257-024-00864-1. Online ahead of print. Am J Clin Dermatol. 2024. PMID: 38789821 No abstract available.
Bone transport induces the release of factors with multi-tissue regenerative potential for diabetic wound healing in rats and patients.
Xie J, Liu X, Wu B, Chen B, Song Q, Guan Y, Gong Y, Yang C, Lin J, Huang M, Tan X, Lai R, Lin X, Zhang S, Xie X, Chen X, Zhang C, Yang M, Nong H, Zhao X, Xia L, Zhou W, Xiao G, Jiang Q, Zou W, Chen D, Lu D, Liu J, Bai X. Xie J, et al. Among authors: gong y. Cell Rep Med. 2024 May 18:101588. doi: 10.1016/j.xcrm.2024.101588. Online ahead of print. Cell Rep Med. 2024. PMID: 38781961 Free article.
10,610 results
You have reached the last available page of results. Please see the User Guide for more information.